ENTX
Closed
Entera Bio Ltd
1.86
-0.04 (-2.11%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.9
Day's Range: 1.85 - 1.96
Send
sign up or login to leave a comment!
When Written:
1.16
Entera Bio Ltd is a clinical-stage biotechnology company that focuses on developing orally delivered large molecule therapeutics for various indications. Its proprietary technology platform enables the oral delivery of proteins, peptides, and other molecules that are typically administered through injections. The company's lead product candidate, EB613, is a once-weekly oral parathyroid hormone (PTH) analog for the treatment of osteoporosis and hypoparathyroidism. Entera Bio also has a collaboration agreement with Amgen Inc. to develop an oral formulation of an undisclosed biologic drug. The company was founded in 2010 and is headquartered in Jerusalem, Israel.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








